Genmab — November 2024
-
Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting https://ir.genmab.com/news-releases/news-release-details/genmab-showcase-strength-and-breadth-comprehensive-epcoritamab
-
another one then for you
Genmab to Present at Jefferies London Healthcare Conference https://ir.genmab.com/news-releases/news-release-details/genmab-present-jefferies-london-healthcare-conference-1 -
Dette skulle være en konkurrent til Carvykti https://finance.yahoo.com/news/arcellx-present-clinical-data-phase-140000917.html
-
Klart nok. Erzo skal jo være et off the shelf produkt, helst i subkutan version, som med frontrunner i ryggen bliver godkendt til 1. linje på rekordtid. De der så relapser og bliver cd38 refraktære kan overgå til car-t, få komplet respons og leve fint til deres dages ende.
-
-
Godmorgen
-
Genmab stiller med 20 indlæg ved ASH-konference https://proinvestor.com/investornyt/1238337/genmab-stiller-med-20-indlaeg-ved-ash-konference
-
Genmab to Highlight Epcoritamabs Promising Role in Non-Hodgkin Lymphoma Treatment at ASH Annual Meeting https://csimarket.com/news/genmab-to-highlight-epcoritamab-s-promising-role-in-non-hodgkin-lymphoma-treatment-at-ash-annual-meeting2024-11-06026109
-
Minhua Chu
@chuminhua432
?? $ABBV AbbVie's BLA for epcoritamab (Epkinly) has been accepted by China's NMPA. https://x.com/chuminhua432/status/1854089849185460624
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind